Skip to main content
OpenTrials

Clinical trial condition

Respiratory Hypersensitivity

Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.

4,464 public trials 329 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Hypersensitivity trial results

Recruiting

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

NCT05562466

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site Mendoza, Mendoza Province, Argentina
View all 64 locations
View Trial Details
Recruiting

TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

NCT06829784

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • The People's Hospital of Bozhou Bozhou, Anhui, China
  • Anhui Chest Hoispital Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Lu'an People's Hospital of Anhui Province Lu'an, Anhui, China
View all 101 locations
View Trial Details
Recruiting

Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

NCT07444567

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Asthma, Autoimmune Diseases, +26 more
Locations
  • Research Site Aurora, Colorado, United States
  • Research Site Bethesda, Maryland, United States
  • Research Site Ann Arbor, Michigan, United States
  • Research Site Northfield, New Jersey, United States
View all 45 locations
View Trial Details
Recruiting

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma

NCT05222529

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Novartis Investigative Site Rousse, Bulgaria
  • Novartis Investigative Site Sevlievo, Bulgaria
  • Novartis Investigative Site Sofia, Bulgaria
  • Novartis Investigative Site Ibague, Tolima Department, Colombia
View all 23 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.

NCT05776927

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Novartis Investigative Site Krugersdorp, Gauteng, South Africa
  • Novartis Investigative Site Lenasia, Gauteng, South Africa
  • Novartis Investigative Site Germiston, Gauteng, South Africa
View Trial Details
Recruiting

CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma

NCT07241117

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +7 more
Locations
  • Affinia healthcare, 2220 Lemp Ave St Louis, Missouri, United States
  • Affinia healthcare, 1717 Biddle Street St Louis, Missouri, United States
  • Affinia healthcare, 4414 North Florissant Avenue St Louis, Missouri, United States
  • Family Care Heath Center, 4352 Manchester Ave St Louis, Missouri, United States
View Trial Details
Recruiting

A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population

NCT06419413

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Research Site Chengdu, Sichuan, China
  • Research Site Beijing, China
  • Research Site Changsha, China
  • Research Site Dongguan, China
View all 21 locations
View Trial Details
Recruiting

A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

NCT07456033

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Newport Beach, California, United States
  • GSK Investigational Site Aventura, Florida, United States
  • GSK Investigational Site Kissimmee, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
View all 17 locations
View Trial Details

Related conditions